Open access
Open access
Powered by Google Translator Translator

Review: Type 2 Myocardial Infarction

29 Jan, 2025 | 10:00h | UTC

Introduction: Type 2 myocardial infarction (MI) is defined by an imbalance in myocardial oxygen supply and demand without atherothrombosis, though it may involve non-atherothrombotic coronary pathologies (e.g., coronary embolism, vasospasm, spontaneous dissection). Challenges in diagnosis and treatment arise from its heterogeneous aetiologies (e.g., sepsis, hypoxia, arrhythmias, or coronary emboli) and frequent overlap with underlying coronary artery disease (CAD). No approaches to investigation or treatments have yet been shown to definitively improve outcomes, and most recommendations remain theoretical strategies in need of validation.

Key Recommendations:

  1. Identify and Correct Underlying Triggers:
    • Recognize that Type 2 MI often occurs in the context of acute illness (e.g., sepsis, hypoxia, anemia, or tachyarrhythmias).
    • Address precipitating factors (e.g., treat infection, restore blood pressure, correct anemia) to reduce further myocardial ischemia.
  2. Distinguish from Type 1 MI When Uncertain:
    • Use intracoronary imaging (OCT/IVUS) primarily to exclude plaque rupture or thrombosis if clinically indicated, especially when symptoms and ECG changes persist, recognizing that its utility in routine practice for Type 2 MI is not yet proven.
    • Carefully re-evaluate patients who remain unstable or have recurrent symptoms after correction of potential triggers, as up to 5% of cases may be reclassified as Type 1 MI.
  3. Risk Stratification and Etiology-Specific Prognosis:
    • Evaluate the likelihood of obstructive coronary artery disease, which is present in ~68% of Type 2 MI cases (e.g., DEMAND-MI study), particularly in older patients or those with risk factors.
    • Perform echocardiography to identify left ventricular dysfunction or valvular abnormalities.
    • Recognize that patients with Type 2 MI due to hypoxia or anemia have approximately double the 1-year mortality risk compared to those with tachyarrhythmia-triggered events.
    • Note that cardiovascular event rates can be similar to those in Type 1 MI, suggesting that future risk is at least as high.
  4. Consider Secondary Prevention in the Context of Limited Evidence:
    • If coronary atherosclerosis is confirmed, single antiplatelet therapy and high-intensity lipid-lowering therapy may be considered; however, there are no dedicated trials validating these approaches exclusively in Type 2 MI.
    • For patients with confirmed left ventricular dysfunction and signs of heart failure, adapt guideline-directed medical therapy carefully, paying close attention to hemodynamic stability.
  5. Monitor Long-Term Outcomes and Address Comorbidities:
    • Recognize that patients with Type 2 MI have poor overall prognosis and high rates of non-cardiovascular mortality, yet they also face substantial cardiovascular risk.
    • Manage chronic comorbidities aggressively (e.g., hypertension, diabetes, dyslipidemia) to minimize recurrent ischemic events.
    • Follow up with echocardiographic or other imaging evaluations where indicated, particularly for patients whose clinical course suggests underlying structural disease.

Conclusion:
Type 2 MI presents significant challenges due to its heterogeneous subtypes (e.g., coronary embolism, spontaneous coronary artery dissection, systemic hypoxia) and frequent diagnostic reclassification. While evidence-based guidance remains limited and no proven interventions have definitively improved outcomes, thorough clinical assessment, targeted imaging to rule out Type 1 MI, and individualized management of comorbidities can potentially improve patient care in this complex condition.

Reference:
Chapman AR, Taggart C, Boeddinghaus J, Mills NL, Fox KAA. Type 2 myocardial infarction: challenges in diagnosis and treatment. European Heart Journal. Published 10 December 2024. DOI: https://doi.org/10.1093/eurheartj/ehae803

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.